Windlas Biotech Limited
Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid pharmaceutical dosage forms and provides a comprehensive range of CDMO services ranging from product discovery, product development, and commercial manufacturing of generic products, including complex generics.
What Windlas files
- Investor Meet58
- Others37
- Updates17
- Board Meeting10
- PPTs8
- Important6
Windlas Biotech Limited has released its consolidated unaudited financial results for the quarter and nine months ending December 31, 2024. The company reported revenue from operations of ₹1,950.19 crore, reflecting a notable year-on-year increase from ₹1,622.13 crore. Total expenses rose to ₹1,787.88 crore, leading to a profit before tax of...
Windlas Biotech Limited has reported its consolidated financial results for the quarter and half-year ended September 30, 2024. The company has recorded a total revenue of ₹80 crore, reflecting a growth of 15% year-over-year. This increase is primarily driven by heightened demand in the pharmaceutical sector and successful market expansion...